AT-43 * MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY COMPARING CEDIRANIB (AZD2171) PLUS GEFITINIB (IRESSA, ZD1839) WITH CEDIRANIB PLUS PLACEBO IN SUBJECTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
Mulholland, P., Krell, D., Khan, I., McBain, C., Patel, C., Wanek, K., Hopkins, K., Jeffries, S., Jager, R., Smith, P., Liu, Q., Stupp, R., Tomlinson, I.Volume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou237.42
Date:
November, 2014
File:
PDF, 31 KB
english, 2014